CD8A and sarcoma: In the sarcoma field both a series of 33 ostesarcoma, including metastastic and localised patients [11], and a large soft tissue sarcoma French study, including several histotypes and also low grades lesions, failed to demonstrate a prognostic role for CD8+ lymphocytes [21].